You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Development of a new pharmacokinetic model incorporating nasal physiologic function to predict nasal drug absorption
- In: SUBMITTED ORALS on Wednesday, 16 April 2014, 14:00-15:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: INOUE, Daisuke (Shujitsu University, School of Pharmacy, Okayama, Japan)
- Co-author(s): Furubayashi, Tomoyuki (Shujitsu University, Okayama, Japan)
Ogawara, Ken-Ichi (Okayama University, Okayama, Japan)
Kimura, Toshikiro (Okayama University, Okayama, Japan)
Higaki, Kazutaka (Okayama University, Okayama, Japan)
Katsumi, Hidemasa (Kyoto Pharmaceutical University, Kyoto, Japan)
Sakane, Toshiyasu (Kyoto Pharmaceutical University, Kyoto, Japan)
Yamamoto, Akira (Kyoto Pharmaceutical University, Kyoto, Japan)
Niwa, Toshiro (Shujitsu University, Okayama, Japan) - Abstract:
Background
Advantages of nasal drug delivery include rapid absorption and avoidance of presystemic metabolism. In addition, nasal drug delivery is non-invasive which improve the patient compliance.
Aims
Although the nasal route has attracted much attention as a systemic delivery route, only a few nasal formulations are on the market now. To.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026